BW

Magellan Aerospace Signs Agreement With the Boeing Company for Exhaust Systems

TORONTO--(BUSINESS WIRE)--Magellan Aerospace Corporation (“Magellan”) announced today the signing of a contract extension with The Boeing Company (“Boeing”), to manufacture large and complex nacelle exhaust systems for the 767 program. The fabricated metallic assemblies will be produced and delivered from Magellan’s facility in Middletown, Ohio. The continuation of this agreement…
Leer más...

ECS Wins $138M US Postal Service AGT Contract

ECS will provide enterprise applications and IT support for geospatial analytics and data managementFAIRFAX, Va.--(BUSINESS WIRE)--#ECS--ECS, a leader in advanced technology, science, and digital transformation solutions, has won a seven-year recompete contract valued at $138M in support of the United States Postal Service (USPS) Addressing and Geospatial Technologies (AGT) Professional…
Leer más...

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA® (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

− POSLUMA will be commercially available in the United States in early June 2023 –MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced U.S. Food and Drug Administration (FDA) approval for its optimized,…
Leer más...

Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial

Study demonstrates statistically significant and clinically relevant reduction in annualized bleeding rate compared to prophylaxis and on-demand intravenous regimens Marstacimab, if approved, has the potential to become the first once-weekly subcutaneous treatment for people living with hemophilia B and the first treatment administered as a flat dose for people living…
Leer más...

Golden Minerals to Effect 1-for-25 Reverse Stock Split

GOLDEN, Colo.--(BUSINESS WIRE)--$AUMN #gold--Golden Minerals Company (“Golden Minerals,” “Golden” or the “Company”) (NYSE-A: AUMN and TSX: AUMN) announced today that at its annual meeting of stockholders held on May 26, 2023, its stockholders approved a reverse stock split of the Company’s common stock. On February 24, 2023, the Company’s board…
Leer más...

Karuna Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, at 2:40 p.m. PT (5:40…
Leer más...